NIRAPARIB vs NITRAZEPAM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRAPARIB vs NITRAZEPAM: Safety Overview
| Metric | NIRAPARIB | NITRAZEPAM |
|---|---|---|
| Total FAERS Reports | 21,634 | 1,165 |
| Deaths Reported | 1,370 | 365 |
| Death Rate | 6.3% | 31.3% |
| Hospitalizations | 4,892 | 466 |
| Average Patient Age | 65.7 yrs | 51.2 yrs |
| % Female Patients | 98.5% | 54.1% |
| FDA Approval Date | Apr 26, 2023 | N/A |
| Manufacturer | GlaxoSmithKline LLC | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | N/A |